In addition, MV-carrying EGFR can be taken up by endothelial cells which in turn activates MAPK and Akt pathways, this will lead to the endogenous expression of VEGF, followed by the activation of VEGF receptor-2 and tumor angiogenesis (Al-Nedawi et al., 2009). The gene discussed is AKT1; the disease is neoplasm.